ID

34244

Description

Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01226888

Link

https://clinicaltrials.gov/show/NCT01226888

Keywords

  1. 1/15/19 1/15/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

January 15, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostate Cancer NCT01226888

Eligibility Prostate Cancer NCT01226888

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adenocarcinoma of the prostate
Description

Adenocarcinoma of prostate

Data type

boolean

Alias
UMLS CUI [1]
C0007112
scheduled to initiate gnrh agonist or antagonist treatment with an intended treatment duration of 12 months or greater
Description

GnRH Agonist Scheduled | GnRH antagonist Scheduled

Data type

boolean

Alias
UMLS CUI [1,1]
C2267073
UMLS CUI [1,2]
C0205539
UMLS CUI [2,1]
C1268855
UMLS CUI [2,2]
C0205539
ecog performance status of 0 or 1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
ability to understand and the willingness to sign a written informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
65 years of age or younger
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
diagnosis of diabetes
Description

Diabetes Mellitus

Data type

boolean

Alias
UMLS CUI [1]
C0011849
ongoing corticosteroid use
Description

Adrenal Cortex Hormones

Data type

boolean

Alias
UMLS CUI [1]
C0001617
gnrh agonist or antagonist treatment within the last 2 years
Description

GnRH Agonist | GnRH antagonist

Data type

boolean

Alias
UMLS CUI [1]
C2267073
UMLS CUI [2]
C1268855
ongoing beta-blocker use
Description

Adrenergic beta-1 Receptor Antagonists

Data type

boolean

Alias
UMLS CUI [1]
C0304516
body mass index of greater than 30
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855

Similar models

Eligibility Prostate Cancer NCT01226888

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
GnRH Agonist Scheduled | GnRH antagonist Scheduled
Item
scheduled to initiate gnrh agonist or antagonist treatment with an intended treatment duration of 12 months or greater
boolean
C2267073 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
C1268855 (UMLS CUI [2,1])
C0205539 (UMLS CUI [2,2])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
ability to understand and the willingness to sign a written informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
65 years of age or younger
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus
Item
diagnosis of diabetes
boolean
C0011849 (UMLS CUI [1])
Adrenal Cortex Hormones
Item
ongoing corticosteroid use
boolean
C0001617 (UMLS CUI [1])
GnRH Agonist | GnRH antagonist
Item
gnrh agonist or antagonist treatment within the last 2 years
boolean
C2267073 (UMLS CUI [1])
C1268855 (UMLS CUI [2])
Adrenergic beta-1 Receptor Antagonists
Item
ongoing beta-blocker use
boolean
C0304516 (UMLS CUI [1])
Body mass index
Item
body mass index of greater than 30
boolean
C1305855 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial